Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 80

Bupivacaine Liposomes vs. Bupivacaine for pain relief after laparoscopic hepatobiliary pancreatic surgery

Official title: Effect of Bupivacaine Liposomes or Bupivacaine for Ultrasound-guided CMB on Postoperative Analgesia in Laparoscopic Hepatobiliary Pancreatic Surgery: a Prospective, Single Blind, Completely Randomized, Active Controlled Clinical Trial

Run by Huazhong University of Science and Technology · NCT06737341 · Data updated 2026-11-12

This trial tests whether liposome-encapsulated bupivacaine provides better postoperative pain relief than standard bupivacaine for people undergoing laparoscopic hepatobiliary pancreatic surgery.

More Postoperative Analgesia trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorHuazhong University of Science and Technology
Academic / other
Locations2 sites (Wuhan, Hubei and 1 other locations)
StatusRecruiting
StartedOctober 8, 2025
Main results expectedFebruary 1, 2027
Study endsFebruary 1, 2027
Registry record updatedJuly 6, 2026
Trial IDNCT06737341 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–80 years old with ASA I–III undergoing laparoscopic hepatobiliary pancreatectomy or similar hepatobiliary procedures.

Probably not a fit

Patients who do not respond to regional anesthesia or who have contraindications to regional blocks or Liposomal bupivacaine may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized phase 4 study, adults undergoing laparoscopic hepatobiliary pancreatic surgery receive an ultrasound-guided costal margin block with either bupivacaine liposomes plus standard bupivacaine or standard bupivacaine alone. All participants follow a standardized anesthesia and postoperative analgesia protocol, with pain monitored via the visual analog scale and managed with an opioid-sparing regimen as needed. The primary aim is to determine if the liposomal formulation extends analgesia and reduces opioid requirements compared with conventional bupivacaine. Safety data, including adverse events related to nerve blocks and local anesthetics, are collected throughout the postoperative period. The study uses a complete randomization scheme and compares outcomes between the two groups."

Why it matters

Potential benefit: If successful, patients may experience longer-lasting pain control and reduced opioid use after surgery.

How similar studies have gone: Previous regional anesthesia studies show promise for liposomal formulations, with some trials indicating longer analgesia but results vary by procedure.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-80 years old ASA Level I-III Laparoscopic Hepatobiliary Pancreatic Surgery

Exclusion Criteria:

* Body Mass Index (BMI) ≥ 30 kg/m ² or ≤ 15 kg/m ² Known alcohol or drug abuse History of upper abdominal surgery Congenital coagulation dysfunction Localized or systemic infection Peripheral neuropathy Unable to understand the research plan

Where it's running

  • Tongji Hospital
    Wuhan, Hubei, China
    Recruiting
  • Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. 1095 Jiefang Avenue, Wuhan City, Hubei Province
    Wuhan, Hubei, China
    Not yet recruiting

Study contacts

  • Principal investigator: Wei Mei, MD — Tongji Medical College, Huazhong University of Science and Technology
  • Study coordinator: Li Xu, MD
  • Email: 65022661@qq.com
  • Phone: 86-13277070358

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.